Well Told Grants

Federal grant recipients / California

Federal grants to Versapeutics Inc

San Diego, California · Small businesses · UEI EGSGJKXHKBN5

Versapeutics Inc in San Diego, California received $7.0 million in federal grants from fiscal 2021 to 2025, across 6 awards. Its largest program was Extramural Research Programs in the Neurosciences and Neurological Disorders, with $6.0 million. In fiscal 2025 it was awarded $1.5 million.

From USAspending.gov award records, updated November 7, 2026.

By year

Federal grants to Versapeutics Inc by fiscal year
Fiscal yearAwardsAmount
FY 20211$256,122
FY 20222$993,671
FY 20232$2.9 million
FY 20241$1.4 million
FY 20251$1.5 million

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Versapeutics Inc

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
Extramural Research Programs in the Neurosciences and Neurological Disorders 93.8534$6.0 million
Aging Research 93.8662$988,162

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services6$7.0 million

Largest awards

The 6 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
Preclinical toxicology study of intrathecal VERSAMAB-101 for spinal cord injury treatment - project summary/abstract spinal cord injury (SCI) is estimated to affect between 249,000 and 363,000 americans, with about 17,730 new injuries occurring each year. There are around 42000 sci patients that are
ASST_NON_R44NS127712_075 on USAspending
Extramural Research Programs in the Neurosciences and Neurological DisordersSeptember 17, 2024$2.9 million
Toxicology and efficacy studies of intrathecal VERSAMAB-101 for spinal cord injury treatment - project summary/abstract spinal cord injury (SCI) is estimated to affect between 249,000 and 363,000 americans, with about 17,730 new injuries occurring each year. There are around 42000 sci patients that
ASST_NON_R44NS120397_075 on USAspending
Extramural Research Programs in the Neurosciences and Neurological DisordersSeptember 18, 2023$2.4 million
Developing therapeutic antibodies for alzheimer's disease - project summary/abstract millions of americans suffer from alzheimer’s disease and there are currently no therapies available to prevent or slow the progression of the disease. The unmet medical needs of individuals with alzheimer’s disease
ASST_NON_R43AG078094_075 on USAspending
Aging ResearchJuly 28, 2022$498,534
Pharmacokinetics and efficacy of intrathecal VERSAMAB-101 delivery foracute spinal cord injury - project summary/abstract every year in the united states, approximately 17,800 people suffer acute spinal cord injuries (SCI). While recent advances in the medical management of sci have led to improveme
ASST_NON_R43NS127712_075 on USAspending
Extramural Research Programs in the Neurosciences and Neurological DisordersMarch 25, 2022$495,137
Developing therapeutic antibodies for alzheimer's disease - project summary/abstract millions of americans suffer from alzheimer’s disease and there are currently no therapies available to prevent or slow the progression of the disease. The unmet medical needs of individuals with alzheimer’s disease
ASST_NON_R43AG085809_075 on USAspending
Aging ResearchSeptember 14, 2023$489,628
Preclinical development of VERSAMAB-101 for spinal cord injury - project summary/abstract acute spinal cord injury (SCI) is a traumatic event that results in the loss of normal motor, sensory, and autonomic function in over 17,000 individuals in the us every year. Currently, there are no fda approve
ASST_NON_R43NS120397_075 on USAspending
Extramural Research Programs in the Neurosciences and Neurological DisordersMay 13, 2021$256,122

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Versapeutics Inc get?

$7.0 million in 6 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Versapeutics Inc the most?

The Department of Health and Human Services, with $7.0 million in 6 awards.

What is Versapeutics Inc's largest federal grant?

$2.9 million under Extramural Research Programs in the Neurosciences and Neurological Disorders, with its first action in the period on September 17, 2024. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund Versapeutics Inc?

Its largest are Extramural Research Programs in the Neurosciences and Neurological Disorders and Aging Research.

Other grant recipients in San Diego

Largest federal grant recipients in California · Federal grants in California